Lilly, ImClone shares steady amid merger talk
Stock in Indianapolis-based Eli Lilly and Co. and ImClone Systems Inc. fell slightly today – a day after reports surfaced that Lilly has made a $6.1 billion offer for the New York-based cancer drug developer. Lilly shares fell 40 cents to $43.30, and ImClone stock slipped 11 cents to $65.24. The declines came on a […]